IRIDEX (IRIX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 11, 2025, to address eight key proposals, including board elections, auditor ratification, equity plan amendments, and charter modernization.
Revised Proposal Four reduces the proposed increase in authorized common stock from 100,000,000 to 63,500,000 shares and allows shareholder actions by written consent.
Board recommends voting in favor of all proposals, especially the Restated Charter, to modernize governance and support strategic flexibility.
Voting matters and shareholder proposals
Proposals include electing five directors, ratifying BPM LLP as auditor, approving issuance of Novel Shares, amending the charter, amending the equity incentive plan, advisory votes on executive compensation and its frequency, and potential adjournment.
Shareholders of record as of April 14, 2025, are eligible to vote; revised proxy card reflects changes to Proposal Four.
Board unanimously recommends voting "FOR" all proposals, with special emphasis on the Restated Charter Proposal.
Board of directors and corporate governance
Board size and composition can be changed only by board resolution; vacancies filled by majority board vote.
No cumulative voting for directors; directors serve until successors are elected and qualified.
Board empowered to adopt, amend, or repeal bylaws, with stockholder amendments subject to bylaw provisions.
Latest events from IRIDEX
- Q2 revenue was $12.6M, net loss narrowed, and liquidity improved with new funding.IRIX
Q2 20242 Feb 2026 - Q3 revenue fell 10% year-over-year, but cost cuts and new reimbursement policies target Q4 breakeven.IRIX
Q3 202414 Jan 2026 - Q4 revenue and margins improved, with strategic investment supporting a positive 2025 outlook.IRIX
Q4 202424 Dec 2025 - Registration allows major stockholder to resell 4.95M shares, raising dilution and liquidity risks.IRIX
Registration Filing16 Dec 2025 - Innovative laser platforms and cost discipline drive growth and margin expansion in key eye care markets.IRIX
Sidoti's Year End Virtual Investor Conference11 Dec 2025 - Shareholders will vote on director elections, major share issuances, and key governance changes.IRIX
Proxy Filing2 Dec 2025 - Restated Charter proposal seeks to modernize governance and expand authorized shares.IRIX
Proxy Filing2 Dec 2025 - Shareholders will vote on major equity issuances, governance updates, and executive compensation.IRIX
Proxy Filing2 Dec 2025 - Key votes include director elections, share increases, and executive pay, with online voting promoted.IRIX
Proxy Filing2 Dec 2025